4
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0001209191-22-060693
Director bought 27,000 shares at an average $1.89 ($51,108)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Martell Christopher Director | 2022-12-08 | Purchase | +3,050 | $1.68 | $5,124 | 128,050 | D |
| Martell Christopher Director | 2022-12-09 | Purchase | +23,950 | $1.92 | $45,984 | 152,000 | D |
| Open-market purchases · 27,000 sh · avg $1.89 · $51,108 | |||||||
Loading xslF345X03/doc4.xml…